All-metal devices, known as the ASR XL, were developed by DePuy, a division of Johnson & Johnson, and can leach chromium and cobalt particles into patients' blood, studies have found.
The ASR XL was recalled in 2010, but possibly as many as 500,000 patients - men and women - may still have them, federal experts say.
Last month, the U.S. Food and Drug Administration updated its alert to physicians about the implants, saying problems with them include pain, loosening, malpositioning, allergic reactions and dislocation. The problems occur regardless of gender.
Dr. Geoffrey Westrich, director of research at the Hospital for Special Surgery in Manhattan, said while the California analysis is intriguing, it is far from the be-all and end-all of gender differences in hip implant surgeries.
"We have tens of thousands of cases (in a database) and when I looked at our registry, we did not see that women fared worse than men in the short run," he said, referring to a three-year period similar to the California research.
However, in a 2011 study, he and his collaborators found in a project including Long Island, N.Y., patients, that women tended to wait longer before hip- or knee-joint replacement surgery and that they report greater pain than men. His investigation involved 6,000 people.